Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.


Regarding anticoagulation strategies, is there a role for tissue plasminogen activator (tPA)? If so, what is the indication for it and who would you use it on?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on July 14, 2021

Moderator: Danielle Davison, MD
Speakers: Travis Murphy MD; Katrina Hawkins, MD; Carrie L. Griffiths, PharmD, BCCCP, FCCM

This educational activity was funded in part by a cooperative agreement with the Centers for Disease Control and Prevention (grant number 1 NU50CK000566-01-00). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). Its contents do not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.


Estimated Time: 01:17 min

Categories: Disaster, Pharmacology,
Content Type: Microlearning,